Knowledge Center
Patent / Jan 01, 1978
Esters of 16.alpha.- or 16.beta.-methyl-9.alpha.-chloro- or -fluorosteroids with high topical activity
Source:
US 4024131
Pregnadienedione derivs. I (R = H, OH, OAc; R1 = H, COBu, COEt; R2 = H, COEt; R3 = Cl, F) (9 compds.) were prepd. Thus 16.beta.-methyl-9,11-epoxy- 17.alpha.-hydroxy-1,4-pregnadiene-3,20-dione was hydrochlorinated, I (R-R2 = H, R3 = Cl) trifluoroacetylated, I (R = R1 = H, R2 = CF3CO, R3 = Cl) treated with BuCO2H, I (R = H, R1 = COBu, R2 = CF3CO, R3 = Cl) hydrolyzed to give I (R = R2 = H, R1 = COBu, R3 = Cl) which had a topical vasoconstrictor potency of 180 relative to fluocinolone 100.
Also in the Knowledge Center
/ Aug 31, 2023
Spray Freeze Drying of Biologics: A Review and Applications for Inhalation Delivery
Read more
Scientific Article
/ Mar 01, 2023
Framework for the validation of mechanistic and hybrid models as Process Analytical tools in the pharmaceutical Industry
Read more
Scientific Article
Scientific Article